The article implies that the four DNA-damaging agents activate JNK, p38, and extracellular signal-regulated kinase (ERK), thereby increasing phosphorylation and ATF2-dependent transcriptional activity in human breast cancer BT474 cells. The gene discussed is MAPK14; the disease is breast carcinoma.